ClearBridge Investments’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,239,573
Closed -$25.7M 1229
2017
Q3
$25.7M Buy
1,239,573
+904
+0.1% +$15.3K 0.02% 399
2017
Q2
$18.3M Buy
1,238,669
+5,834
+0.5% +$97.2K 0.02% 437
2017
Q1
$19.7M Sell
1,232,835
-10,032
-0.8% -$145K 0.02% 425
2016
Q4
$15.7M Sell
1,242,867
-3,336
-0.3% -$62.1K 0.02% 434
2016
Q3
$34.9M Sell
1,246,203
-1,627
-0.1% -$54.6K 0.04% 339
2016
Q2
$43.7M Buy
1,247,830
+184,830
+17% +$5.81M 0.05% 287
2016
Q1
$29.1M Buy
1,063,000
+96,217
+10% +$2.83M 0.03% 352
2015
Q4
$33.1M Buy
966,783
+423,829
+78% +$13.2M 0.04% 341
2015
Q3
$15.6M Buy
542,954
+35,670
+7% +$1.53M 0.02% 442
2015
Q2
$22.7M Buy
507,284
+7,211
+1% +$271K 0.02% 416
2015
Q1
$17.3M Sell
500,073
-40
-0% -$1.09K 0.02% 451
2014
Q4
$13.7M Buy
+500,113
New +$12.1M 0.01% 484

Other funds holding DPLO

ClearBridge Investments's DPLO Position: Q4 2017 in Review

ClearBridge Investments sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2017, closing a stake of 1,239,573 shares — an estimated $25.7M sold.

ClearBridge Investments first reported a position in DPLO in Q4 2014 and held it in 12 quarters. The position peaked at $43.7M in Q2 2016. 200 funds tracked by Wall St. Rank hold DPLO as of Q4 2017.

  • ClearBridge Investments reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2017 after selling out during the quarter.
  • ClearBridge Investments sold 1,239,573 DIPLOMAT PHARMACY, INC. shares in Q4 2017, an estimated $25.7M.
  • ClearBridge Investments first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 12 quarters.
  • ClearBridge Investments's DIPLOMAT PHARMACY, INC. position peaked at $43.7M in Q2 2016.
  • 200 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2017.

Based on ClearBridge Investments's 13F filing for Q4 2017, filed 14 Feb 2018.